NEO
NeoGenomics, Inc.
Stock
$18.47+0.69 (+3.88%)Close Oct 2, 2026
- Operating income, 2025
- −$116M
Operating income
Operating income by fiscal year
| Period | Operating income | YoY |
|---|---|---|
| 2025 | −$116M | — |
| 2024 | −$92M | — |
| 2023 | −$108M | — |
| 2022 | −$158M | — |
| 2021 | −$119M | — |
| 2020 | −$14M | — |
| 2019 | $13M | +29.5% |
| 2018 | $10M | +246.0% |
| 2017 | $2.9M | +34.7% |
| 2016 | $2.2M | — |
| 2015 | −$5.6M | — |
| 2014 | $2.2M | −30.1% |
| 2013 | $3.2M | +162.1% |
| 2012 | $1.2M | — |
| 2011 | −$409K | — |
| 2010 | −$3.0M | — |